Jefferies Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-394,640
Closed -$4.52M 1817
2021
Q1
$4.41M Buy
394,640
+242,715
+160% +$2.56M 0.04% 421
2020
Q4
$1.73M Buy
+151,925
New +$1.66M 0.01% 756
2020
Q1
Sell
-22,871
Closed -$304K 2351
2019
Q4
$304K Sell
22,871
-37,622
-62% -$415K ﹤0.01% 2059
2019
Q3
$519K Sell
60,493
-47,717
-44% -$464K ﹤0.01% 1863
2019
Q2
$1.18M Buy
108,210
+100,867
+1,374% +$1.13M 0.01% 1201
2019
Q1
$83K Sell
7,343
-7,023
-49% -$78.4K ﹤0.01% 2149
2018
Q4
$125K Sell
14,366
-5,409
-27% -$62.1K ﹤0.01% 1933
2018
Q3
$306K Sell
19,775
-22,586
-53% -$357K ﹤0.01% 1865
2018
Q2
$678K Buy
+42,361
New +$627K ﹤0.01% 1444
2018
Q1
Sell
-35,237
Closed -$442K 2467
2017
Q4
$442K Buy
+35,237
New +$460K ﹤0.01% 1795
2017
Q3
Sell
-29,954
Closed -$474K 2470
2017
Q2
$474K Sell
29,954
-100
-0.3% -$1.45K ﹤0.01% 1633
2017
Q1
$429K Buy
+30,054
New +$411K ﹤0.01% 1675
2016
Q4
Sell
-42,112
Closed -$560K 2334
2016
Q3
$560K Buy
+42,112
New +$492K ﹤0.01% 1569
2015
Q3
Sell
-42,865
Closed -$433K 2646
2015
Q2
$433K Buy
+42,865
New +$498K ﹤0.01% 1623
2014
Q2
Sell
-17,693
Closed -$183K 2217
2014
Q1
$183K Sell
17,693
-42,088
-70% -$473K ﹤0.01% 1755
2013
Q4
$582K Buy
+59,781
New +$537K ﹤0.01% 1077

Other funds holding IRWD

Jefferies Group's IRWD Position: Q2 2021 in Review

Jefferies Group sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2021, closing a stake of 394,640 shares — an estimated $4.52M sold.

Jefferies Group first reported a position in IRWD in Q4 2013 and held it in 16 quarters. The position peaked at $4.41M in Q1 2021. 208 funds tracked by Wall St. Rank hold IRWD as of Q2 2021.

  • Jefferies Group reported no remaining Ironwood Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Jefferies Group sold 394,640 Ironwood Pharmaceuticals shares in Q2 2021, an estimated $4.52M.
  • Jefferies Group first reported a position in Ironwood Pharmaceuticals in Q4 2013 and held it in 16 quarters.
  • Jefferies Group's Ironwood Pharmaceuticals position peaked at $4.41M in Q1 2021.
  • 208 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2021.

Based on Jefferies Group's 13F filing for Q2 2021, filed 16 Aug 2021.